<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01176201</url>
  </required_header>
  <id_info>
    <org_study_id>S337.1.005</org_study_id>
    <secondary_id>2010-020006-15</secondary_id>
    <nct_id>NCT01176201</nct_id>
  </id_info>
  <brief_title>14-C ADME (Absorption, Disposition, Metabolism and Excretion) Study in Man</brief_title>
  <official_title>An Open-Label Study to Determine ADME of 14C Labeled SLV337 After a Single Dose of an Oral Suspension</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Abbott Products</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Abbott</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is an open-label study to determine the ADME (Absorption, Disposition, Metabolism and
      Excretion) of 14C labeled SLV337 after a single dose of an oral suspension.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The Absorption, Disposition, Metabolism and Excretion of SLV337 will be investigated after a
      single dose of an oral suspension of 14C-SLV337.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>July 2010</start_date>
  <completion_date type="Actual">October 2010</completion_date>
  <primary_completion_date type="Actual">October 2010</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>AUC0-t, AUC, Cmax, tmax, t1/2, λz, CL/F, Vz/F, MRT (mean residence time) for SLV337 (Part 1 and Part 2)</measure>
    <time_frame>Part 1: 5 days Part 2: 8 days</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>AUC0-t, AUC, Cmax, tmax, t1/2, λz, CL/F, Vz/F, MRT (mean residence time) for SLV337 acyl-glucoronide (Part 2)</measure>
    <time_frame>Part 2: 8 days</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Excretion balance of total 14C-radioactivity (Part 2)</measure>
    <time_frame>Part 2: 8 days</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Total 14C-radioactivity (Part 2)</measure>
    <time_frame>Part 2: 8 days</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Metabolic profiling and identification of 14C-labeled parent compound and metabolites of SLV337 in plasma, urine and feces (Part 2)</measure>
    <time_frame>Part 2: 8 days</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Safety and tolerability assessments including adverse events, clinical laboratory tests, ECG and vital signs (Part 1 and Part 2)</measure>
    <time_frame>Part 1: 19 days Part 2: 15 days</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">12</enrollment>
  <condition>Healthy Subjects</condition>
  <arm_group>
    <arm_group_label>A</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>400 mg suspension</description>
  </arm_group>
  <arm_group>
    <arm_group_label>B</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>5 x 200 mg immediate release capsule</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>SLV337 suspension</intervention_name>
    <description>400 mg experimental</description>
    <arm_group_label>A</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>SLV337 capsule</intervention_name>
    <description>5 x 200 mg immediate release capsule</description>
    <arm_group_label>B</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria

          -  BMI 18 - 28 kg/m2

          -  SBP 90-140

          -  DBP 50-90

        Exclusion Criteria

          -  Seizures,

          -  Orthostatic hypotension
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>55 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Anita Vanderlaan</last_name>
    <role>Study Director</role>
    <affiliation>Abbott Healthcare Products BV</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Site Reference ID/Investigator# 61345</name>
      <address>
        <city>Zuidlaren</city>
        <zip>9370 AE</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Netherlands</country>
  </location_countries>
  <verification_date>August 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 20, 2010</study_first_submitted>
  <study_first_submitted_qc>August 4, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 5, 2010</study_first_posted>
  <last_update_submitted>August 25, 2011</last_update_submitted>
  <last_update_submitted_qc>August 25, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 26, 2011</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>SLV337</keyword>
  <keyword>Diabetes</keyword>
  <keyword>Relative bioavailability</keyword>
  <keyword>ADME</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

